9:00am - 5:00pm

Office Hours Mon. - Fri.

800.799.2234

Call Us For Free Consultation

Facebook

Twitter

11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)

Estimated reading time: < 1 min

Condition

Mesothelioma, Malignant

Estimated Enrollment: 20

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Observational

Study Design Allocation: Time Perspective: Prospective

Study ID Numbers: 1287

Study First Received: June 26, 2015

Last Updated: November 18, 2016

Estimated Primary Completion Date: September 2017

Primary Outcome Measures:

Variation of SUVmax (Maximal Standardized Uptake Value) in patients undergoing talc pleurodesis

Sponsors and Collaborators:

Istituto Clinico Humanitas

Result Received: No Study Results Posted

Website Link: https://ClinicalTrials.gov/show/NCT02519049

Was this article helpful?
Views: 45